Canada approves AstraZeneca's COVID-19 vaccine

Feb 26 (Reuters) - Canada's drug regulator approved AstraZeneca's (AZN) COVID-19 vaccine on Friday, the third inoculation to get a green light.

The vaccine was approved under Canada's interim order system, which allows for accelerated approvals similar to the U.S. Food and Drug Administration's emergency use authorizations. (Reporting by Allison Martell and Julie Gordon; Editing by Steve Scherer and Alex Richardson)

Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.